CN Stock MarketDetailed Quotes
603087 Gan & Lee Pharmaceuticals.
- 46.38
- -0.64-1.36%
Market Closed Nov 15 15:00 CST
27.88BMarket Cap48.01P/E (TTM)
47.50High46.35Low68.11KlotVolume46.99Open47.02Pre Close319.56MTurnover1.23%Turnover Ratio81.94P/E (Static)601.07MShares62.7052wk High2.49P/B25.69BFloat Cap31.9052wk Low51.72Limit Up553.92MShs Float203.16Historical High42.32Limit Down2.45%Amplitude30.33Historical Low0.20Dividend TTM46.92Avg Price35.63KlotAsk0.43%Div YieldTTM100Lot Size29.07KlotBid
Gan & Lee Pharmaceuticals. Key Stats
EPS
According to the latest financial report of Gan & Lee Pharmaceuticals., the latest earnings per share (TTM) for the company is 0.85. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Gan & Lee Pharmaceuticals.'s latest financial report to see how much their book value per share (BVPS) is currently at 18.65.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Gan & Lee Pharmaceuticals. shows that the company's current ratio is 8.04, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Gan & Lee Pharmaceuticals., the quick ratio is 6.77, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Gan & Lee Pharmaceuticals.? The latest ROE figure is 4.62%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Gan & Lee Pharmaceuticals., the total asset return on investment (ROA) is 4.24%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Gan & Lee Pharmaceuticals.'s latest financial report to see how their gross margin is doing - currently at 75.36%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Gan & Lee Pharmaceuticals., the net profit margin is 22.60%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data